Edition:
United States

Aptevo Therapeutics Inc (APVO.OQ)

APVO.OQ on NASDAQ Stock Exchange Global Select Market

5.54USD
22 Jun 2018
Change (% chg)

$-0.11 (-1.95%)
Prev Close
$5.65
Open
$5.60
Day's High
$5.97
Day's Low
$5.49
Volume
85,663
Avg. Vol
31,688
52-wk High
$6.30
52-wk Low
$1.18

Select another date:

Mon, Jan 8 2018

BRIEF-Aptevo Therapeutics Begins Patient Dosing In Phase 2 Clinical Trial Of Otlertuzumab In Peripheral T-Cell Lymphoma

* APTEVO THERAPEUTICS BEGINS PATIENT DOSING IN PHASE 2 CLINICAL TRIAL OF OTLERTUZUMAB IN PERIPHERAL T-CELL LYMPHOMA Source text for Eikon: Further company coverage:

Select another date: